Geron Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 4, 2026, reporting its first quarterly net income since the commercial launch of RYTELO.

Key Highlights

  • Quarterly net income of $1.350 million for the three months ended September 30, 2026, compared to a net loss of $18.428 million in the same period of 2025, according to the filing.
  • Q3 2026 product revenue, net was $60.114 million, up from $47.167 million in Q3 2025, as reported in the condensed consolidated statements of operations.
  • Nine-month net loss of $18.972 million for the period ended September 30, 2026, compared to a net loss of $54.638 million for the same period in 2025.
  • Total assets stood at $527.106 million as of September 30, 2026, down from $570.540 million at December 31, 2025.
  • Accumulated deficit was $1.874813 billion as of September 30, 2026, per the condensed consolidated balance sheet.
  • 644,238,859 shares of common stock were outstanding as of October 30, 2026, as stated on the cover page.
  • Inventory of $126.603 million was reported as of September 30, 2026, compared to $116.636 million at December 31, 2025.

Geron Corporation Reports Q3 2026 Financial Results, Turns Quarterly Profitable

According to the filing, Geron Corporation (NASDAQ:GERN) reported total revenues of $60.190 million for the three months ended September 30, 2026, consisting of $60.114 million in net product revenue and $76 thousand in royalties. This compares to total revenues of $47.227 million in the third quarter of 2025. For the nine months ended September 30, 2026, the company reported total revenues of $169.507 million, up from $135.866 million for the same period in 2025.

The company disclosed total costs and operating expenses of $54.391 million for Q3 2026, compared to $61.114 million in Q3 2025. The Q3 2026 breakdown included cost of goods sold of $6.051 million, research and development expenses of $12.709 million, selling, general and administrative expenses of $35.702 million, and a restructuring credit of $71 thousand. Income from operations for the quarter was $5.799 million, contrasting with a loss from operations of $13.887 million in the prior-year quarter. For the nine months ended September 30, 2026, the company reported a loss from operations of $6.539 million.

The condensed consolidated balance sheet as of September 30, 2026, showed cash and cash equivalents of $69.179 million, marketable securities of $217.300 million, and accounts receivable, net of $45.979 million. Total stockholders' equity was reported at $226.695 million, with additional paid-in capital of $2.101451 billion. Noncurrent debt stood at $120.439 million, and noncurrent liability related to sale of future royalties was $105.724 million. Stock-based compensation for equity-based awards to employees and directors totaled $4.799 million for Q3 2026.

What Was Disclosed

Geron Corporation's 10-Q for the quarter ended September 30, 2026, disclosed a quarterly net income of $1.350 million and nine-month net loss of $18.972 million, with net product revenue of $60.114 million for the quarter and total assets of $527.106 million as of the period end.